Abstract
Molecular epidemiology exploits the fact that viral genomes vary at the nucleotide level while maintaining their essential characteristics at the protein and viron level. Molecular characterization of this nucleotide variation is useful not only for epidemiological purposes but also for investigations into pathogenesis, disease progression, forensics and clinical treatment. Here we will describe the molecular tools that are used in the analysis of viral nucleic acids and discuss the applicability and limitations of the various techniques.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmadian A., Gharizadeh B., Gustafsson A.C., Sterky F., Nyrén P., Uhlén M., and Lundeberg J. 2000. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem 280:103–10.
Ansorge W., Sproat B.S., Stegemann J., and Schwager C. 1986. A non-radioactive automated method for DNA sequence determination. J Biochem Biophys Methods 13:315–23.
Arens M. 1999. Methods for subtyping and molecular comparison of human viral genomes. Clin Microbiol Rev 12:612–26.
Arens M. 2001. Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV. J Clin Virol 22:11–29.
Barlow K.L., Green J., and Clewley J.P. 2000. Viral genome characterisation by the heteroduplex mobility and heteroduplex tracking assays. Rev Med Virol 10:321–35.
Garcia C.A., Ahmadian A., Gharizadeh B., Lundeberg J., Ronaghi M., and Nyrén P. 2000. Mutation detection by pyrosequencing: sequencing of exons 5–8 of the p53 tumor suppressor gene. Gene 253:249–57.
Germer J.J., Rys P.N., Thorvilson J.N., and Persing D.H. 1999. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol 37:2625–30.
Gharizadeh B., Kalantari M., Garcia C.A., Johansson B., and Nyrén P. 2001. Typing of human papillomavirus by pyrosequencing. Lab Invest 81:673–9.
Graves D.J. 1999. Powerful tools for genetic analysis come of age. Trends Biotechnol 17:127–34.
Guo Z., Liu Q., and Smith L.M. 1997. Enhanced discrimination of single nucleotide polymorphisms by artificial mismatch hybridization. Nat Biotechnol 15:331–5.
Gustafsson A.C., Guo Z., Hu X., Ahmadian A., Brodin B., Nilsson A., Ponten J., Ponten F., and Lundeberg J. 2001. HPV-related cancer susceptibility and p53 codon 72 polymorphism. Acta Derm Venereol 81:125–9.
Hanna G.J., Johnson V.A., Kuritzkes D.R., Richman D.D., Martinez-Picado J., Sutton L., Hazelwood J.D., and D’Aquila R.T. 2000. Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse tran scriptase. J Clin Microbiol 38:2715–21.
Ju J., Ruan C., Fuller C.W., Glazer A.N., and Mathies R.A. 1995. Fluorescence energy transfer dye-labeled primers for DNA sequencing and analysis. Proc Natl Acad Sci USA 92:4347–51.
Koch N., Tamalet C., Tivoli N., Fantini J., and Yahi N. 2001. Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase. J Clin Virol 21:153–62.
Koch N., Yahi N., Colson P., Fantini J., and Tamalet C. 1999. Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis. J Virol Methods 80:25–31.
Kozal M.J., Shah N., Shen N., Yang R., Fucini R., Merigan T.C., Richman D.D., Morris D., Hubbell E., Chee M., and Gingeras T.R. 1996. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat Med 2:753–9.
Kronick M. 1997. Heterozygote determination using automated DNA sequencing technology. In Laboratory methods for the detection of mutations and polymorphisms in DNA, Taylor G. R., ed. CRC Press.
Kuiken C., Foley B., Hahn B., Marx P., Mccutchan F., Mellors J., Mullins J., Wolinsky S., and B. K. 2000. HIV Sequence Compendium, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory.
Le Pogam S., Dubois F., Christen R., Raby C., Cavicchini A, and Goudeau A. 1998. Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping. J Clin Microbiol 36: 1461–3.
Lee J. H., Roth W.K., and Zeuzem S. 1997. Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays. J Hepatol 26:1001–9.
Leitner T., Halapi E., Scarlatti G., Rossi P., Albert J., Fenyo E.M., and Uhlén M. 1993. Analysis of heterogeneous viral populations by direct DNA sequencing. Biotechniques 15:120–7.
Lipshutz R.J., Morris D., Chee M., Hubbell E., Kozal M.J., Shah N., Shen N., Yang R., and Fodor S.P. 1995. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 19:442–7.
Maxam A.M. and Gilbert W. 1977. A new method for sequencing DNA. Proc Natl Acad Sci USA 74:560–4.
McPherson J.D., Marra M., Hillier L., Waterston R.H., Chinwalla A., Wallis J., Sekhon M., Wylie K., Mardis E.R., Wilson R.K., el al. 2001. A physical map of the human genome. Nature 409:934–41.
Monstein H., Nikpour-Badr S., and Jonasson J. 2001. Rapid molecular identification and subtyping of Helicobacter pylori by pyrosequencing of the 16S rDNA variable V1 and V3 regions. FEMS Microbiol Lett 199:103–7.
Murray V. 1989. Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nucleic Acids Res 17:88–89.
Nyren P., Pettersson B., and Uhlen M. 1993. Solid phase DNA minisequencing by an enzymatic luminometric inorganic pyrophosphate detection assay. Anal Biochem 208: 171–5.
O’ Meara D., Wilbe K., Leitner T., Hejdeman B., Albert J., and Lundeberg J. 2001. Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing. J Clin Microbiol 39:464–73.
Odeberg J., Yun Z., Sonnerborg A., Uhlen M., and Lundeberg J. 1995. Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing. J Clin Microbiol 33:1870–4.
Prober J.M., Trainor G.L., Dam R.J., Hobbs F.W., Robertson C.W., Zagursky R.J., Cocuzza A.J., Jensen M.A., and Baumeister K. 1987. A system for rapid DNA sequencing with fluorescent chainterminating dideoxynucleotides. Science 238:336–41.
Ronaghi M. 2001. Pyrosequencing sheds light on DNA sequencing. Genome Res 11:3–11.
Ronaghi M., Uhlén M., and Nyrén P. 1998. A sequencing method based on real-time pyrophosphate. Science 281:363–365.
Sanger F., Nicklen S., and Coulson A.R. 1977. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–7.
Schuurman R., Demeter L., Reichelderfer P., Tijnagel J., de Groot T., and Boucher C. 1999. Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol 37:2291–6.
Servais J., Lambert C., Fontaine E., Plesseria J.M., Robert I., Arendt V., Staub T., Schneider F., Hemmer R., Burtonboy G., and Schmit J.C. 2001. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy. J Clin Microbiol 39:454–9.
Smith L.M., Sanders J.Z., Kaiser R.J., Hughes P., Dodd C., Connell C.R., Heiner C., Kent S.B., and Hood L.E. 1986. Fluorescence detection in automated DNA sequence analysis. Nature 321:674–9.
Stuyver L., Wyseur A., Rombout A., Louwagie J., Scarcez T., Verhofstede C., Rimland D., Schinazi R.F., and Rossau R. 1997. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother 41:284–91.
Tabor S. and Richardson C.C. 1987. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proc Natl Acad Sci USA 84:4767–71.
Tabor S. and Richardson C.C. 1995. A single residue in DNA polymerases of the Escherichia coli DNA polymerase I family is critical for distinguishing between deoxy-and dideoxyribonucleotides. Proc Natl Acad Sci USA 92:6339–43.
Vahey M., Nau M.E., Barrick S., Cooley J.D., Sawyer R., Sleeker A.A., Vickerman P., Bloor S., Larder B., Michael N.L., and Wegner S.A. 1999. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms. J Clin Microbiol 37:2533–7.
Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., and Holt R.A. 2001. The sequence of the human genome. Science 291: 1304–51.
Wilson J.W., Bean P., Robins T., Graziano F., and Persing D.H. 2000. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay. J Clin Microbiol 38:3022–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
O’Meara, D., Lundeberg, J. (2002). DNA Technology for Molecular Analysis of Viruses. In: Leitner, T. (eds) The Molecular Epidemiology of Human Viruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1157-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1157-1_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5420-8
Online ISBN: 978-1-4615-1157-1
eBook Packages: Springer Book Archive